Illumina earnings points to worrying signs for consumer genetics industry

Illumina earnings points to worrying signs for consumer genetics industry

STAT Plus: Illumina earnings points to worrying signs for consumer genetics industry

By DAMIAN GARDE

APSTOCK

New figures suggest consumer genetics companies are ordering fewer genotyping arrays, which suggests customers are buying fewer DNA tests.

READ MORE